Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

Exclusive: Third death revealed in China's popular but opaque trials

A patient with an autoimmune disease has died after receiving an experimental genetic medicine from a biotech startup in China, Endpoints News has learned. The Shanghai-based company, RiboX Therapeutics, recently received a green light from ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 18 August →